These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27125842)

  • 1. Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.
    Phillips LM; Zhou X; Cogdell DE; Chua CY; Huisinga A; R Hess K; Fuller GN; Zhang W
    J Pathol; 2016 Jul; 239(3):355-64. PubMed ID: 27125842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP2 expression predicts IDH-mutant glioma patient survival.
    Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
    Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration.
    Mendes KN; Wang GK; Fuller GN; Zhang W
    Int J Oncol; 2010 Jul; 37(1):143-53. PubMed ID: 20514406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein 2 promotes glioma development and progression.
    Dunlap SM; Celestino J; Wang H; Jiang R; Holland EC; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11736-41. PubMed ID: 17606927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1.
    Martino-Echarri E; Fernández-Rodríguez R; Bech-Serra JJ; Plaza-Calonge Mdel C; Vidal N; Casal C; Colomé N; Seoane J; Canals F; Rodríguez-Manzaneque JC
    Oncotarget; 2014 Jun; 5(12):4295-304. PubMed ID: 24962328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.
    Moore LM; Holmes KM; Smith SM; Wu Y; Tchougounova E; Uhrbom L; Sawaya R; Bruner JM; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16675-9. PubMed ID: 19805356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.
    Liu Y; Li F; Yang YT; Xu XD; Chen JS; Chen TL; Chen HJ; Zhu YB; Lin JY; Li Y; Xie XM; Sun XL; Ke YQ
    Oncogene; 2019 Mar; 38(11):1815-1831. PubMed ID: 30368528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network.
    Holmes KM; Annala M; Chua CY; Dunlap SM; Liu Y; Hugen N; Moore LM; Cogdell D; Hu L; Nykter M; Hess K; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3475-80. PubMed ID: 22345562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma.
    Verma BK; Kondaiah P
    J Neurooncol; 2020 Sep; 149(2):209-217. PubMed ID: 32803659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
    Chua CY; Liu Y; Granberg KJ; Hu L; Haapasalo H; Annala MJ; Cogdell DE; Verploegen M; Moore LM; Fuller GN; Nykter M; Cavenee WK; Zhang W
    Oncogene; 2016 Feb; 35(6):738-47. PubMed ID: 25893308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP2 promotes glioma tumor stem cell expansion and survival.
    Hsieh D; Hsieh A; Stea B; Ellsworth R
    Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion.
    Patil SS; Railkar R; Swain M; Atreya HS; Dighe RR; Kondaiah P
    J Neurooncol; 2015 Jun; 123(2):225-35. PubMed ID: 25944386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.
    Shiraki Y; Mii S; Enomoto A; Momota H; Han YP; Kato T; Ushida K; Kato A; Asai N; Murakumo Y; Aoki K; Suzuki H; Ohka F; Wakabayashi T; Todo T; Ogawa S; Natsume A; Takahashi M
    J Pathol; 2017 Dec; 243(4):468-480. PubMed ID: 28888050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of insulin-like growth factor binding protein genes and its hypoxic regulation in U87 glioma cells depends on ERN1 mediated signaling pathway of endoplasmic reticulum stress.
    Minchenko DO; Kharkova AP; Karbovskyi LL; Minchenko OH
    Endocr Regul; 2015 Apr; 49(2):73-83. PubMed ID: 25960008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.
    Zheng S; Houseman EA; Morrison Z; Wrensch MR; Patoka JS; Ramos C; Haas-Kogan DA; McBride S; Marsit CJ; Christensen BC; Nelson HH; Stokoe D; Wiemels JL; Chang SM; Prados MD; Tihan T; Vandenberg SR; Kelsey KT; Berger MS; Wiencke JK
    Neuro Oncol; 2011 Mar; 13(3):280-9. PubMed ID: 21339190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
    Liu Y; Song C; Shen F; Zhang J; Song SW
    PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm.
    Zhang W; Wang H; Song SW; Fuller GN
    Brain Pathol; 2002 Jan; 12(1):87-94. PubMed ID: 11770904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study.
    Wang H; Wang H; Zhang W; Fuller GN
    Technol Cancer Res Treat; 2006 Jun; 5(3):195-9. PubMed ID: 16700616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis.
    Sehgal P; Kumar N; Praveen Kumar VR; Patil S; Bhattacharya A; Vijaya Kumar M; Mukherjee G; Kondaiah P
    Mol Cancer; 2013 Jun; 12():63. PubMed ID: 23767917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.
    Turner KM; Sun Y; Ji P; Granberg KJ; Bernard B; Hu L; Cogdell DE; Zhou X; Yli-Harja O; Nykter M; Shmulevich I; Yung WK; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3421-6. PubMed ID: 25737557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.